Estrogen Receptor-Positive Breast Carcinoma Clinical Trials

10 clinical trials for Estrogen Receptor-Positive Breast Carcinoma across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial — RECRUITING · PHASE3
• Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial — RECRUITING · PHASE2
• Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors — RECRUITING · PHASE2
• Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy — RECRUITING
• Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery — RECRUITING · PHASE2
• Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer — RECRUITING · PHASE2
• Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial — SUSPENDED · PHASE3
• High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer — SUSPENDED · PHASE2
• Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca — ACTIVE_NOT_RECRUITING · PHASE2
• Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer — WITHDRAWN · NA

Refine this search